胶质母细胞瘤。第二部分：未来方向。
Glioblastoma. Part II: Future directions.
作者信息
Salacz Michael E, Watson Kenneth R, Schomas David A
机构信息
Saint Luke's Brain Tumor Center, Kansas City, Mo, USA.
出版信息
Mo Med. 2011 Jul-Aug;108(4):289-91.
Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary malignant brain neoplasm, recent advances in the treatment of Glioblastoma Multiforme (GBM) have offered new hope for patients, families and clinicians. In the first part of this two-part evidence-based review, we focused on the multidisciplinary advances that have established the current standard of care practice in the management of GBM. The second part discusses ongoing research efforts, both ongoing clinical trial efforts as well as some of the newer technologies that are forming the promise of the future.
尽管并不常见，但“脑癌”是困扰人类的最令人恐惧的疾病之一。虽然它仍被视为原发性恶性脑肿瘤最致命的形式之一，但多形性胶质母细胞瘤（GBM）治疗方面的最新进展为患者、家属和临床医生带来了新的希望。在这个分为两部分的循证综述的第一部分中，我们重点关注了在GBM管理方面确立当前护理标准实践的多学科进展。第二部分讨论了正在进行的研究工作，包括正在进行的临床试验工作以及一些构成未来希望的较新技术。
Zotero 插件